Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Focetria vs Begrivac for H1N1 in HIV Patients
NCT01032408Phase 3Completed
- Sponsor
- Chiltern International
- Start
- Apr 2010
- Primary completion
- Sep 2011
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines, Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) in influenza A H1N1 infection (H1N1), sponsored by Chiltern International. Started Apr 2010; status: completed.
02
Drugs
Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
03
Conditions
influenza A H1N1 infection (H1N1)
Beyond the preview
Go deeper on NCT01032408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01032408.